5-((4-Bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]imidazole-6-carboxamide, 98%, 250mg

BETAMETHASONE 17-VALERATE, 98%, 1g

(S)-2-amino-4,4,4-trifluoro-butyric acid hydrochloride, 97%, 1g

1-Nitro-2-(2,2,2-trifluoroethoxy)benzene, 1g

tert-Butyl 4-[(4-chlorobenzyl)carbamoyl]-4-methylpiperidine-1-carboxylate, 250mg

Condensatore di Abbe 1,25 NA con apertura per campo scuro e vetrino per contrasto di fase. Senza vetrino per campo scuro e senza vetrini per contrasto di fase

Magnesium bromide, anhydrous, 98.0%, 100g

Methyl 3-(4-Ethynylphenyl)propanoate, 95.0%, 1g

(R)-3-Aminotetrahydrofuran hydrochloride, 97.0%, 100g

3-Fluoro-2-thiophenecarboxylic acid, 95.0%, 10g

2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride, 97.0%, 5g

(2,1,3-Benzothiadiazol-4-yl)methanamine hydrochloride, 95+%, 250mg

(1-Methyl-1H-pyrazol-4-yl)methanamine hydrochloride, 95.0%, 1g